Sign in to use this feature.

Years

Between: -

Article Types

Countries / Regions

Search Results (94)

Search Parameters:
Journal = JoR

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
13 pages, 288 KiB  
Article
Independent Predictors of Mycoplasma pneumoniae Infection: A Retrospective Cohort Study Among Hospitalized Adults in an East Texas Health Facility
by Menkeoma Laura Okoli, Ibuchim Chinemerem Okoli, Abuoma Chisom Okoli, Ikechukwu Umezurike and Celestine Ishiekwene
J. Respir. 2025, 5(3), 13; https://doi.org/10.3390/jor5030013 - 8 Aug 2025
Abstract
Background: Community-acquired pneumonia in the United States accounts for over five million cases annually, with an estimated one million hospitalizations. About two million of these annual cases and over 100,000 annual hospitalizations are caused by mycoplasma pneumonia. Although mycoplasma can sometimes present as [...] Read more.
Background: Community-acquired pneumonia in the United States accounts for over five million cases annually, with an estimated one million hospitalizations. About two million of these annual cases and over 100,000 annual hospitalizations are caused by mycoplasma pneumonia. Although mycoplasma can sometimes present as a benign disease, it can cause severe complications, which are referred to as pulmonary and extrapulmonary complications. This study aims to identify independent predictors of Mycoplasma pneumoniae infection among adult patients in our facility in East Texas. Methods: This retrospective cohort study used data from the electronic health record (EPIC Systems). Multivariate analyses were conducted to determine variables independently associated with mycoplasma pneumonia. The main outcome variable was the presence of mycoplasma pneumonia as indicated by serology testing. Results: Among 1714 adult patients in our study population who underwent antibody testing, 297 (17.3%) tested positive for mycoplasma pneumonia. Mycoplasma pneumonia was significantly associated with age, sex, race, season, and tobacco use after controlling for other variables. Adults who do not use tobacco had lower odds of having mycoplasma pneumonia compared to adults who are currently using tobacco (OR = 0.64, C.I. = 0.48–0.75). Also, these adults are more likely to have MP during non-respiratory season as compared to respiratory season (OR = 1.25, C.I. = 1.10–1.61). Conclusions: Tobacco use, season, age, race, and sex were all significant predictors of mycoplasma pneumonia. These findings highlight target areas for health care professionals and organizations to tackle to help improve patient health outcomes. Full article
(This article belongs to the Collection Feature Papers in Journal of Respiration)
16 pages, 912 KiB  
Review
Connecting the Dots: Beetroot and Asthma
by Madiha Ajaz, Indu Singh, Lada Vugic, Rati Jani, Shashya Diyapaththugama and Natalie Shilton
J. Respir. 2025, 5(3), 12; https://doi.org/10.3390/jor5030012 - 5 Aug 2025
Viewed by 275
Abstract
Asthma is a persistent ailment that impacts the respiratory system and stands as a formidable public health challenge globally. Inhaled corticosteroids and bronchodilators, while effective in asthma management, are accompanied by side effects and high costs. Recently, nutraceuticals have gained significant attention as [...] Read more.
Asthma is a persistent ailment that impacts the respiratory system and stands as a formidable public health challenge globally. Inhaled corticosteroids and bronchodilators, while effective in asthma management, are accompanied by side effects and high costs. Recently, nutraceuticals have gained significant attention as adjuvant therapy due to their promising outcomes. Given the antioxidant properties, nutrient richness, and an array of health benefits, beetroot and its bioactive compounds have been tested as an adjuvant therapy for asthma management. Although its main bioactive compound, betalains (betanin), has demonstrated promising results in mouse studies, beetroot juice has been found to worsen asthma. This review investigated the full spectrum of active compounds associated with beetroots to understand the underlying factors contributing to the conflicting findings. The finding suggests that individual bioactive compounds, such as phenolic compounds, flavonoids, nitrates, betalains, saponins, vitamins, fiber, and carotenoids, possess asthma-managing properties. However, the consumption of juice may exacerbate the condition. This discrepancy may be attributed to the presence of sugars and oxalates in the juice, which could counteract the beneficial effects of the bioactive compounds. Full article
Show Figures

Graphical abstract

19 pages, 2950 KiB  
Article
Nomogram Based on the Most Relevant Clinical, CT, and Radiomic Features, and a Machine Learning Model to Predict EGFR Mutation Status in Non-Small Cell Lung Cancer
by Anass Benfares, Abdelali yahya Mourabiti, Badreddine Alami, Sara Boukansa, Ikram Benomar, Nizar El Bouardi, Moulay Youssef Alaoui Lamrani, Hind El Fatimi, Bouchra Amara, Mounia Serraj, Mohammed Smahi, Abdeljabbar Cherkaoui, Mamoun Qjidaa, Ahmed Lakhssassi, Mohammed Ouazzani Jamil, Mustapha Maaroufi and Hassan Qjidaa
J. Respir. 2025, 5(3), 11; https://doi.org/10.3390/jor5030011 - 23 Jul 2025
Viewed by 324
Abstract
Background: This study aimed to develop a nomogram based on the most relevant clinical, CT, and radiomic features comprising 11 key signatures (2 clinical, 2 CT-based, and 7 radiomic) for the non-invasive prediction of the EGFR mutation status and to support the timely [...] Read more.
Background: This study aimed to develop a nomogram based on the most relevant clinical, CT, and radiomic features comprising 11 key signatures (2 clinical, 2 CT-based, and 7 radiomic) for the non-invasive prediction of the EGFR mutation status and to support the timely initiation of tyrosine kinase inhibitor (TKI) therapy in patients with non-small cell lung cancer (NSCLC) adenocarcinoma. Methods: Retrospective real-world data were collected from 521 patients with histologically confirmed NSCLC adenocarcinoma who underwent CT imaging and either surgical resection or pathological biopsy for EGFR mutation testing. Five Random Forest classification models were developed and trained on various datasets constructed by combining clinical, CT, and radiomic features extracted from CT image regions of interest (ROIs), with and without feature preselection. Results: The model trained exclusively on the most relevant clinical, CT, and radiomic features demonstrated superior predictive performance compared to the other models, with strong discrimination between EGFR-mutant and wild-type cases (AUC = 0.88; macro-average = 0.90; micro-average = 0.89; precision = 0.90; recall = 0.94; F1-score = 0.91; and accuracy = 0.87). Conclusions: A nomogram constructed using a Random Forest model trained solely on the most informative clinical, CT, and radiomic features outperformed alternative approaches in the non-invasive prediction of the EGFR mutation status, offering a promising decision-support tool for precision treatment planning in NSCLC. Full article
Show Figures

Figure 1

13 pages, 2131 KiB  
Article
Development of a New Treatment for Lung Diseases, Mainly Interstitial Pneumonia, Using Platinum-Palladium: A Pilot Study
by Satoshi Kawakami, Taro Shirakawa, Shoichi Wajima, Yusuke Segawa, Yoshitaka Fukuzawa and Kou Sakabe
J. Respir. 2025, 5(3), 10; https://doi.org/10.3390/jor5030010 - 8 Jul 2025
Viewed by 357
Abstract
Interstitial pneumonia is a general term for diseases in which inflammation occurs mainly in the interstitium of the lung. It is also pointed out that interstitial pneumonia reduces alveolar function and makes it difficult to take in oxygen through inspiration, causing symptoms such [...] Read more.
Interstitial pneumonia is a general term for diseases in which inflammation occurs mainly in the interstitium of the lung. It is also pointed out that interstitial pneumonia reduces alveolar function and makes it difficult to take in oxygen through inspiration, causing symptoms such as dyspnea and coughing, which may eventually lead to respiratory failure. At present, there is no effective treatment, and only conservative treatment exists. This time, we report that the therapeutic effect was confirmed in patients with interstitial pneumonia who took platinum palladium. In this case, improvement tendencies were observed in patients with Idiopathic pulmonary fibrosis (IPF), but improvement tendencies were also observed in many other lung diseases. In order to explore the mechanism, AMPK was measured at the in vitro level, and blood KL-6 and hydrogen peroxide levels in the patient were measured at the in vivo level. AMPK values were significantly elevated by more than 800%, and KL-6 and hydrogen peroxide levels were also significantly decreased by drinking platinum palladium. Platinum palladium exhibits a strong antioxidant effect and is the only substance in the world that can approach all four types of active oxygen. In addition, when it was actually administered to patients, there were cases of dramatic improvement, and it was confirmed that KL-6, a parameter of lung function, decreased in 16 out of 32 patients, and furthermore, oxygen inhalation was completed. Patients were also seen. It was suggested that increasing the number of cases in the future may help improve interstitial pneumonia. Full article
Show Figures

Figure 1

8 pages, 625 KiB  
Article
CT Guided Biopsy—A Review of a Pleural Interventional Service with Regard to Pneumothorax Rates
by Jebelle Sutanto, Grace Mussell, Daniel Mitchell, Wei Hann Ong and Avinash Aujayeb
J. Respir. 2025, 5(3), 9; https://doi.org/10.3390/jor5030009 - 30 Jun 2025
Viewed by 340
Abstract
Introduction: Computed tomography-guided biopsies (CTGB) are essential in diagnosing various conditions, particularly in respiratory medicine, with lung cancer being a primary focus. A significant complication associated with CTGB is pneumothorax, which can occur in up to 26% of cases. At Northumbria Healthcare NHS [...] Read more.
Introduction: Computed tomography-guided biopsies (CTGB) are essential in diagnosing various conditions, particularly in respiratory medicine, with lung cancer being a primary focus. A significant complication associated with CTGB is pneumothorax, which can occur in up to 26% of cases. At Northumbria Healthcare NHS Foundation Trust, a large interventional service collaborates closely with radiologists and respiratory physicians. This study aims to evaluate the incidence of pneumothorax following CTGB. Methods: A retrospective service review was conducted on all lung parenchymal CTGBs performed between April 2011 and July 2023, with approval from the local information governance. Demographic data and clinical outcomes were analyzed using descriptive statistics. Continuous variables are presented as medians with interquartile ranges (IQR), while categorical variables are reported as frequencies and percentages. Results: A total of 1492 CT-guided lung biopsies were analyzed. The median age of patients was 72 years (IQR 10.5), and 50.9% were male. Pneumothorax occurred in 23.8% (n = 355) of cases. Of these, 159 (44.8%) were detected on post-biopsy CT scans. The average number of pleural passes was 1.8 (range 1–4). Among those with pneumothorax, 53.6% had radiologically evident emphysema. The median forced expiratory volume in 1 s (FEV1) was 1.97 L (IQR 1.04). Sixty-seven percent (n = 234) of patients had no pleural contact, and the median lesion size was 26 mm (IQR 24). Seventy-two percent (n = 255) of lesions with pneumothoraces were less than 3 cm deep. Forty-four percent of biopsies were performed using 18 French gauge tru-cut needles. Of the 355 pneumothoraces, 89% (n = 315) were managed conservatively, with 42 requiring pleural intervention (41 small-bore 12 Fr intercostal chest drains and one pleural vent). Symptoms were initially present in 40 cases, and two cases developed symptoms up to 7 days post-procedure. Conclusions: The incidence of pneumothorax is consistent with expected rates, with more occurrences observed in biopsies of smaller lesions lacking pleural contact, lesions with surrounding emphysema, and cases requiring multiple pleural passes. FEV1 does not appear to influence the risk of pneumothorax. Conservative management is generally effective, without significant complications. Full article
Show Figures

Figure 1

12 pages, 554 KiB  
Review
Busting the Myths of DLco for Pulmonary Trainees: Isolated Reductions in DLco and the Relationship with VA
by Ahmad Raza, Nayab Nadeem, Christian Cardillo, Lijo Illipparambil and Aamir Ajmeri
J. Respir. 2025, 5(3), 8; https://doi.org/10.3390/jor5030008 - 24 Jun 2025
Viewed by 801
Abstract
Background: DLco remains one of the most commonly performed tests in the pulmonary lab. An isolated reduction in DLco is a unique abnormality with specific differentials when evaluating a patient with dyspnea. There remains a significant misunderstanding amongst young pulmonologists and pulmonary trainees [...] Read more.
Background: DLco remains one of the most commonly performed tests in the pulmonary lab. An isolated reduction in DLco is a unique abnormality with specific differentials when evaluating a patient with dyspnea. There remains a significant misunderstanding amongst young pulmonologists and pulmonary trainees regarding DLco and its relationship with alveolar volume and kco. Objective: This review aims to provide a physiological basis for the DLco test and bust the myth of “DLco corrected for lung volume.” Method: A systematic review of the available literature regarding alveolar gas-exchange physiology, measurement methods of DLco, the interplay of different variables associated with it, and the causes of its reduction was performed. Focused physiological data were used to put together a comprehensive review of isolated reductions in DLco. The second part of this review addresses the critical and interdependent relationship between DLco and alveolar volume (VA). Results: DLco has a unique relationship with lung volume that needs to be considered while interpreting its value. Diffusion capacity per unit volume (kco) is an independent factor that, when combined with DLco and VA, helps accurately interpret the test and narrow down differentials. Conclusion: DLco is an extremely valuable test and an important prognostic tool in many patients with dyspnea. An isolated reduction in DLco is increasingly recognized these days as an early marker of detection for various pulmonary parenchymal and vascular diseases. A detailed physiopathological explanation, followed by the proposed algorithm, should help pulmonary physicians and trainees understand and implement DLco’s relationships in their daily patient care. Full article
Show Figures

Figure 1

15 pages, 2688 KiB  
Systematic Review
Effects of Structured Exercise Programs on Self-Reported Health-Related Quality of Life in Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by Carl Lawrence Arenos, Franessa Ysabel Dianne Chan Huan-Jacinto, Josephine Anne Lucero, Frederic Ivan Ting, Marvin Jonne Mendoza, Madelaine Amante, Danielle Benedict Sacdalan and John Paulo Vergara
J. Respir. 2025, 5(2), 7; https://doi.org/10.3390/jor5020007 - 13 May 2025
Viewed by 1161
Abstract
Current treatments for metastatic non-small cell lung cancer (NSCLC) have improved survival but remain non-curative, primarily aiming to control disease and to extend life. Structured exercise has demonstrated clinical and quality-of-life benefits in early-stage NSCLC. This systematic review assesses the impact of adjunctive [...] Read more.
Current treatments for metastatic non-small cell lung cancer (NSCLC) have improved survival but remain non-curative, primarily aiming to control disease and to extend life. Structured exercise has demonstrated clinical and quality-of-life benefits in early-stage NSCLC. This systematic review assesses the impact of adjunctive exercise programs on health-related quality of life (HRQoL) in advanced NSCLC patients, with safety as a secondary outcome. Of 1168 studies screened, 13 met the inclusion criteria. All eligible studies were included in the systematic review, and three underwent meta-analysis. Using Synthesis Without Meta-analysis (SWiM), the findings were heterogeneous: four studies showed positive outcomes, two had mixed results, and seven showed negative outcomes. Meta-analysis of studies utilizing the EORTC-C30 tool demonstrated a positive mean difference of 1.57 (95% CI: 0 to 3.14), indicating a trend toward HRQoL improvement. Safety analyses largely revealed no major adverse events related to exercise interventions. Future studies must therefore be designed to account for confounders intrinsic to the underlying disease of study participants to better determine both the efficacy and the safety of structured, adjunctive exercise programs in this patient population. Full article
Show Figures

Figure 1

16 pages, 4512 KiB  
Systematic Review
The Association Between Asthma and Endometriosis: A Systematic Review and Metanalysis
by Maria E. Ramos-Nino, Abraham Agaya Obadiah, Ifesinachi Ogochukwu Ozugha and Prakash V. A. K. Ramdass
J. Respir. 2025, 5(2), 6; https://doi.org/10.3390/jor5020006 - 7 Apr 2025
Cited by 1 | Viewed by 1074
Abstract
Observational studies suggest a comorbid link between asthma and endometriosis, but the evidence remains limited and inconsistent. This study presents a meta-analysis examining this association. A comprehensive search of literature databases was conducted through August 2024. Prevalence rates and odds ratios (ORs) were [...] Read more.
Observational studies suggest a comorbid link between asthma and endometriosis, but the evidence remains limited and inconsistent. This study presents a meta-analysis examining this association. A comprehensive search of literature databases was conducted through August 2024. Prevalence rates and odds ratios (ORs) were calculated to assess the relationship between asthma and endometriosis. For the prevalence analysis, sixteen studies, including 54,856 endometriosis cases and 300,613 controls, were included. The analysis yielded a prevalence of asthma in endometriosis patients of 14.9% (95% CI [10.3, 19.6], p < 0.001), with high heterogeneity (I2 = 99.9%). In the control group, asthma prevalence was 9.1% (95% CI [6.5, 11.6], p < 0.001, I2 = 99.9%). For the odds ratio (OR) analysis, twelve studies, including 295,845 endometriosis cases and 28,030,081 controls, were included. The meta-analysis demonstrated a significant association between asthma and endometriosis with an OR of 1.59 (95% CI [1.22, 2.07], p = 0.0007, I2 = 100%). Subgroup analyses stratified by study region and study type were also conducted. This meta-analysis suggests a significant association between asthma and endometriosis, indicating that common factors underlying these chronic inflammatory diseases may contribute to this comorbidity. The findings support the biological plausibility of this association. Full article
Show Figures

Figure 1

22 pages, 7708 KiB  
Article
Top and Side Leakage Effects on Thermoregulation and Moisture Retention with Facemask Wearing
by Kian Barari, Xiuhua Si, Rozhin Hajian and Jinxiang Xi
J. Respir. 2025, 5(2), 5; https://doi.org/10.3390/jor5020005 - 3 Apr 2025
Viewed by 1189
Abstract
Background/Objectives: Mask-wearing-induced discomfort often leads to unconscious loosening of the mask to relieve the discomfort, thereby compromising protective efficacy. This study investigated how leakage flows affect mask-associated thermoregulation and vapor trapping to inform better mask designs. An integrated ambience–mask–face–airway model with various mask-wearing [...] Read more.
Background/Objectives: Mask-wearing-induced discomfort often leads to unconscious loosening of the mask to relieve the discomfort, thereby compromising protective efficacy. This study investigated how leakage flows affect mask-associated thermoregulation and vapor trapping to inform better mask designs. An integrated ambience–mask–face–airway model with various mask-wearing misfits was developed. Methods: The transient warming/cooling effects, thermal buoyancy force, tissue heat generation, vapor phase change, and fluid/heat/mass transfer through a porous medium were considered in this model, which was validated using Schlieren imaging, a thermal camera, and velocity/temperature measurements. Leakages from the top and side of the mask were analyzed in comparison to a no-leak scenario under cyclic respiration conditions. Results: A significant inverse relationship was observed between mask leakage and facial temperature/humidity. An equivalent impact from buoyancy forces and exhalation flow inertia was observed both experimentally and numerically, indicating a delicate balance between natural convection and forced convection, which is sensitive to leakage flows and critical in thermo-humidity regulation. For a given gap, the leakage fraction was not constant within one breathing cycle but constantly increased during exhalation. Persistently higher temperatures were found in the nose region throughout the breathing cycle in a sealed mask and were mitigated during inhalation when gaps were present. Vapor condensation occurred within the mask medium during exhalation in all mask-wearing cases. Conclusions: The thermal and vapor temporal variation profiles were sensitive to the location of the gap, highlighting the feasibility of leveraging temperature and relative humidity to test mask fit and quantify leakage fraction. Full article
(This article belongs to the Collection Feature Papers in Journal of Respiration)
Show Figures

Figure 1

15 pages, 1720 KiB  
Perspective
Intricacies of Global Tuberculosis Management—EndTB-2035 on the Fence?
by Radha Gopalaswamy and Selvakumar Subbian
J. Respir. 2025, 5(1), 4; https://doi.org/10.3390/jor5010004 - 17 Mar 2025
Viewed by 940
Abstract
Tuberculosis (TB) is a leading cause of death from a single infectious agent in humans. The morbidity and mortality due to TB are further worsened by co-existing health conditions and the emergence of drug-resistant (DR-TB) cases. The WHO has declared TB as a [...] Read more.
Tuberculosis (TB) is a leading cause of death from a single infectious agent in humans. The morbidity and mortality due to TB are further worsened by co-existing health conditions and the emergence of drug-resistant (DR-TB) cases. The WHO has declared TB as a global emergency and endorsed global efforts to improve diagnosis, and treatment while reducing the catastrophic cost in an EndTB strategy in 2013, with a vision to create a TB-free world. In the past decade, molecular diagnostic tools, such as nucleic acid amplification technologies (NAATs), have replaced the conventional smear microscopy of TB, thus offering better bacteriological confirmation and case detection along with drug resistance in pulmonary and extrapulmonary samples. Follow-on testing using a more advanced targeted next-generation sequencing (tNGS) system has improved the diagnosis of cases resistant to first- and second-line anti-TB drugs, including newer ones. TB treatment has been improved with the introduction of newer drugs including an all-oral regimen for DR-TB, thereby improving patient compliance. Improved TB prevention is achieved through the broadening of BCG vaccination as well as preventive therapy for asymptomatic, latent TB (LTBI) cases, which, otherwise, can reactivate to symptomatic disease. However, the recent goal of the WHO’s EndTB-2035 strategy has been met with significant challenges in the areas of implementing improved diagnosis and treatment modalities in resource-limited TB endemic countries. The complexity of global TB management is confounded by malnutrition, comorbidities with other infectious and non-infectious diseases, and the socio-economic landscape of vulnerable populations. Political commitment to universal health coverage (UHC), including service coverage and reduction in catastrophic cost, are some of the essential components that need to be addressed to achieve the EndTB strategy. In this perspective, we have highlighted the intricacies of global TB management and summarized some of the key challenges that may keep the WHO’s EndTB-2035 strategy on the fence. Full article
(This article belongs to the Collection Feature Papers in Journal of Respiration)
Show Figures

Figure 1

10 pages, 1943 KiB  
Communication
Evaluation of the Applicability of ChatGPT in Patient Education on Obstructive Sleep Apnea
by Cristina López-Riolobos, Juan Riestra-Ayora, Beatriz Raboso Moreno, Nora Lebrato Rubio, José María Diaz García, Cristina Vaduva, Indira Astudillo Rodríguez, Leonardo Saldaña Pérez, Fernando García Prieto, Sara Calero Pardo and Araceli Abad Fernández
J. Respir. 2025, 5(1), 3; https://doi.org/10.3390/jor5010003 - 4 Mar 2025
Viewed by 1542
Abstract
ChatGPT (Chat-Generative Pre-trained Transformer) is an accessible and innovative tool for obtaining healthcare information. This study evaluates the quality and reliability of information provided by ChatGPT 4.0® regarding Obstructive Sleep Apnea (OSA), comparing it with responses from sleep medicine specialists. Thirty frequently [...] Read more.
ChatGPT (Chat-Generative Pre-trained Transformer) is an accessible and innovative tool for obtaining healthcare information. This study evaluates the quality and reliability of information provided by ChatGPT 4.0® regarding Obstructive Sleep Apnea (OSA), comparing it with responses from sleep medicine specialists. Thirty frequently asked questions about OSA were posed to ChatGPT 4.0® and two expert physicians. Responses from both sources (V1: AI and V2: Medical Experts) were blindly evaluated by a panel of six specialists using a five-point Likert scale across precision, relevance, and depth dimensions. The AI-generated responses (V1) achieved a slightly higher overall score compared to those from medical experts (V2), although the difference was not statistically significant (p > 0.08). These results suggest that both sources offer comparable quality and content. Additionally, ChatGPT’s responses were clear and easily understandable, providing an accessible explanation of OSA pathology. Full article
Show Figures

Figure 1

17 pages, 7890 KiB  
Article
NTRK Gene Expression in Non-Small-Cell Lung Cancer
by Jair Gutierrez-Herrera, M. Angeles Montero-Fernandez, Georgia Kokaraki, Luigi De Petris, Raul Maia Falcão, Manuel Molina-Centelles, Ricardo Guijarro, Simon Ekman and Cristian Ortiz-Villalón
J. Respir. 2025, 5(1), 2; https://doi.org/10.3390/jor5010002 - 27 Feb 2025
Cited by 1 | Viewed by 1668
Abstract
Background/Objectives: Since the discovery of oncogenic neurotrophic receptor tyrosine kinase (NTRK) gene fusions in colorectal cancer in 1986, their understanding has evolved, particularly in non-small-cell lung cancer (NSCLC) over the past five years. NTRK rearrangements, involving NTRK1, NTRK2, and NTRK3, drive tumorigenesis and [...] Read more.
Background/Objectives: Since the discovery of oncogenic neurotrophic receptor tyrosine kinase (NTRK) gene fusions in colorectal cancer in 1986, their understanding has evolved, particularly in non-small-cell lung cancer (NSCLC) over the past five years. NTRK rearrangements, involving NTRK1, NTRK2, and NTRK3, drive tumorigenesis and have been identified in various adult and pediatric cancers, with over 80 different fusion variants in several type of cancers. Detecting these rearrangements is crucial for targeted therapy strategies. The aim of this study is detect, compare and analyse these mutations in NSCLC patients of a cohort of 482 cases from Karolinska University Hospital. Methods: We conducted an initial screening using pan-TRK immunohistochemistry (IHC) to analyze the material. Positive cases were further examined through whole-exome sequencing (WES) with next-generation sequencing (NGS) to confirm the presence of fusions. Additionally, to deepen our understanding, we utilized Ingenuity Pathway Analysis (IPA) software, an artificial intelligence-driven technology, to explore the molecular pathways involved in lung cancer. Results: TRK overexpression was detected in 4.56% of cases via IHC. Among 15 pan-TRK-positive cases, WES confirmed fusions in 3, revealing a higher prevalence of NTRK1 (6.6%) and NTRK2 (13.3%) fusions, while no NTRK3 fusions were observed. Conclusions: Our findings confirm the low prevalence of these neoplasms as well as the need for a molecular test to confirm rearrangements or other potentially treatable mutations and raise other questions regarding their clinical use. However, there is an acceptable correlation between pan-TRK IHC and NTRK mutations, but not enough to determine NTRK fusions. Full article
(This article belongs to the Collection Feature Papers in Journal of Respiration)
Show Figures

Figure 1

15 pages, 3125 KiB  
Article
A Whole-Body Physiology Model to Investigate Respiratory Function During Exercise Across Different Age Cohorts
by Austin Baird, Rachel A. Umoren, Steven A. White, Megan Gray and Taylor L. Sawyer
J. Respir. 2025, 5(1), 1; https://doi.org/10.3390/jor5010001 - 31 Jan 2025
Viewed by 1541
Abstract
Background: There is a limitation in understanding complete cardiopulmonary function during moments of exhaustive exercise due to invasive measurement techniques. We asked how cardiopulmonary function is perturbed during times of exercise in different age cohorts: 6–11 and 11–18. We sought to broadly analyze [...] Read more.
Background: There is a limitation in understanding complete cardiopulmonary function during moments of exhaustive exercise due to invasive measurement techniques. We asked how cardiopulmonary function is perturbed during times of exercise in different age cohorts: 6–11 and 11–18. We sought to broadly analyze how age and oxidative stress during exercise differ across age cohorts. Methods: We present a whole-body physiology model that connects the nervous, cardiovascular, respiratory, and oxygen transport and binding systems. We connect these models using a lumped parameter representation of the cardiovascular and respiratory systems. Results: we observe distinct age-related difference in physiological response to exercise. These responses consist of respiratory, cardiovascular, and nervous system perturbations that are distinct across these age groups. Full article
(This article belongs to the Collection Feature Papers in Journal of Respiration)
Show Figures

Figure 1

12 pages, 2485 KiB  
Article
Assessing the Safety and Efficacy of Self-Expanding Metallic Y Stents in a Community Medicine Setting
by Daniel Jacob Smith, Russell Vo, Parker Lachowsky, Ann Davis, Isha Puri and Sai Karan Vamsi Guda
J. Respir. 2024, 4(4), 223-234; https://doi.org/10.3390/jor4040020 - 16 Dec 2024
Viewed by 1155
Abstract
Self-Expanding Metallic (SEM) Y stents are a newer form of stent that is gaining popularity outside the USA, but still has limited data, especially in a community medicine setting. This study analyzed efficacy and complication rates in 14 patients who had a SEM [...] Read more.
Self-Expanding Metallic (SEM) Y stents are a newer form of stent that is gaining popularity outside the USA, but still has limited data, especially in a community medicine setting. This study analyzed efficacy and complication rates in 14 patients who had a SEM Y stent placed between August 2022 and June 2024 at Harris Methodist Hospital in Fort Worth, Texas for either central airway obstruction (CAO) or fistulae. Of the 14 patients, 11 were requiring supplemental oxygen or mechanical ventilation prior to stent placement. Post-stenting 42.9% had decreased oxygen requirements, 21.4% unchanged, 14.3% increased, and 21.4% remained on room air. Complications included mucus plugging (42.9%), infection (35.7%), and granulation tissue (14.3%). There was no statistically significant correlation between gender/age and complications (p = 0.879/0.490, respectively). Complication rates were similar when compared to silicone Y stents based on literature review. In conclusion, SEM Y stents are a safe and effective alternative stent intended for palliative treatment with similar success and complications that can be easily and effectively implemented in a community hospital, with the added benefit of being able to be placed with flexible bronchoscopy. Full article
Show Figures

Figure 1

13 pages, 452 KiB  
Review
The 2023 British Thoracic Society Guideline for Pleural Disease Update on Malignant Pleural Effusion
by Kavita Sivabalah, Haval Balata, Chris Craig, Alaa Alsaaty, Kevin Conroy, Wei Hann Ong and Avinash Aujayeb
J. Respir. 2024, 4(4), 210-222; https://doi.org/10.3390/jor4040019 - 26 Nov 2024
Cited by 1 | Viewed by 7691
Abstract
The management of malignant pleural effusions (MPEs) has developed hugely since the publication of the management of an MPE: British Thoracic Society (BTS) Pleural Disease Guideline 2010. The presence of an MPE reflects advanced or metastatic disease (excluding malignant pleural mesothelioma) and thus [...] Read more.
The management of malignant pleural effusions (MPEs) has developed hugely since the publication of the management of an MPE: British Thoracic Society (BTS) Pleural Disease Guideline 2010. The presence of an MPE reflects advanced or metastatic disease (excluding malignant pleural mesothelioma) and thus the management of MPE often focuses on symptomatic relief of symptoms and improving quality of life. We provide a review of the 2023 BTS guidance in relation to malignant pleural effusions and specific points on imaging and systemic anti-cancer treatment by concentrating on a hypothetical patient vignette. Full article
(This article belongs to the Collection Feature Papers in Journal of Respiration)
Show Figures

Figure 1

Back to TopTop